|
Role of ASXL1 mutations in myeloid malignancies
|
5K08CA160647-05
|
$169,884
|
$169,884
|
ABDEL-WAHAB, OMAR
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
|
3R01CA140622-05S1
|
$54,171
|
$54,171
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
IRF-8 as a Negative Regulator of CD11b+Gr-1+ Myeloid Cell Production and Function
|
5R01CA140622-05
|
$388,425
|
$388,425
|
ABRAMS, SCOTT
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Role of p27 in chronic myeloid leukemia and its potential as a therapeutic target
|
5R00CA151670-04
|
$248,585
|
$248,585
|
AGARWAL, ANUPRIYA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Adult Leukemia Research Center
|
5P01CA018029-40
|
$4,225,448
|
$169,018
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission)
|
5R01CA160433-04
|
$336,150
|
$336,150
|
ARMANIOS, MARY
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA082103-17S2
|
$50,000
|
$1,000
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S3
|
$124,967
|
$2,499
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S4
|
$199,969
|
$3,999
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
3P30CA082103-17S5
|
$158,600
|
$3,172
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Cancer Center Support Grant
|
5P30CA082103-17
|
$7,292,969
|
$145,859
|
ASHWORTH, ALAN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
|
5R01CA184798-02
|
$671,104
|
$671,104
|
ATALLAH, EHAB
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Improved therapeutic approaches for hematological disorder treated with tyrosine
|
5R01CA155091-04
|
$317,475
|
$317,475
|
AZAM, MOHAMMAD
|
CINCINNATI CHILDRENS HOSP MED CTR
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S1
|
$37,429
|
$749
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-41S2
|
$125,000
|
$2,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-41
|
$4,288,496
|
$85,770
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
A novel hematopoietic stem cell population
|
5F31CA180604-02
|
$47,398
|
$23,699
|
BALCEREK, JOANNA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Cancer Center Support Grant
|
2P30CA042014-26
|
$1,639,000
|
$65,560
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S1
|
$31,248
|
$1,250
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S2
|
$50,000
|
$2,000
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S3
|
$249,799
|
$9,992
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S4
|
$123,315
|
$4,933
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S5
|
$150,000
|
$6,000
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA042014-26S6
|
$178,513
|
$7,141
|
BECKERLE, MARY
|
UNIVERSITY OF UTAH
|
|
Resistance of CML Stem Cells to Imatinib (Gleevec)
|
7R01CA095684-12
|
$275,378
|
$275,378
|
BHATIA, RAVI
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Microenvironmental Regulation of Leukemia Stem Cells
|
7R01CA172447-03
|
$305,025
|
$305,025
|
BHATIA, RAVI
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-05
|
$170,100
|
$85,050
|
BLEAKLEY, MARIE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Role of Tcl1 and Par-4 in regulation of chronic lymphocytic leukemia
|
5R01CA165469-03
|
$381,420
|
$381,420
|
BONDADA, SUBBARAO
|
UNIVERSITY OF KENTUCKY
|
|
Mechanisms linking RAS signals to disordered hematopoiesis and myeloid neoplasia
|
5R01CA173085-03
|
$328,888
|
$328,888
|
BRAUN, BENJAMIN
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
BCR-ABL 1 RT-QPCR TEST FOR IMPROVED MONITORING OF CML PERIOD OF PERFORMANCE: 09/
|
261201500009C
|
$1,489,494
|
$1,489,494
|
BROWN, JUSTIN
|
ASURAGEN, INC.
|
|
The Tisch Cancer Institute - Cancer Center Support Grant
|
1P30CA196521-01
|
$1,695,000
|
$457,650
|
BURAKOFF, STEVEN
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
|
5R01CA167169-03
|
$321,625
|
$321,625
|
CALABRETTA, BRUNO
|
THOMAS JEFFERSON UNIVERSITY
|
|
Therapeutic Targeting of Leukemia-Microenvironmental Interactions
|
5R01CA166280-03
|
$318,513
|
$318,513
|
CALVI, LAURA
|
UNIVERSITY OF ROCHESTER
|
|
International Symposium on Juvenile Myelomonocytic Leukemia (JMML)
|
2R13CA132568-09
|
$4,000
|
$4,000
|
CHAN, REBECCA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Role of Shp2 in FLT3-ITD-Induced Leukemogenesis
|
5R01CA134777-05
|
$319,550
|
$319,550
|
CHAN, REBECCA
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Roles of SIRT1 in normal hematopoietic and leukemic stem cells
|
5R01CA143421-05
|
$313,740
|
$313,740
|
CHEN, WENYONG
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Fanconi anemia pathway in DNA damage repair
|
5R01CA157448-04
|
$327,850
|
$327,850
|
CHEN, JUNJIE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML
|
5R21CA159203-02
|
$196,406
|
$196,406
|
COREY, SETH
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Genetic Analysis of Myeloproliferative Disease
|
3R01CA076167-12S1
|
$82,142
|
$82,142
|
COWELL, JOHN
|
GEORGIA REGENTS UNIVERSITY
|
|
Genetic Analysis of Myeloproliferative Disease
|
5R01CA076167-12
|
$307,125
|
$307,125
|
COWELL, JOHN
|
GEORGIA REGENTS UNIVERSITY
|
|
Mechanisms of Leukemogenesis in Down Syndrome
|
5R01CA101774-13
|
$303,965
|
$303,965
|
CRISPINO, JOHN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
TOWARD AN UNDERSTANDING OF CLL PROGRESSION
|
5R01CA151319-05
|
$34,752
|
$34,752
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S1
|
$395,573
|
$3,956
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S2
|
$124,964
|
$1,250
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S3
|
$68,339
|
$683
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S4
|
$200,000
|
$2,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-08
|
$1,535,000
|
$15,350
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-40S1
|
$120,000
|
$1,200
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-40S2
|
$123,768
|
$1,238
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support (CORE) Grant
|
3P30CA016672-40S3
|
$60,000
|
$600
|
DEPINHO, RONALD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $32,556,862
|